Eikon Therapeutics Inc. Common Stock
EIKN | NASDAQ
$5.31
-$0.04 (-0.75%)
At close: Oct 30, 2026, 4:00 PM ET
$5.49
+$0.18 (+3.39%)
Pre-market:
Nov 2, 2026, 4:00 AM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 |
|---|---|
PE Ratio | -2.44 |
PEG Ratio | n/a |
PS Ratio | n/a |
PB Ratio | -0.92 |
P/FCF Ratio | -3.45 |
P/OCF Ratio | -4.31 |
OCF/S Ratio | n/a |
Debt / Equity Ratio | -0.29 |
Quick Ratio | 6.34 |
Current Ratio | 6.34 |
Asset Turnover | n/a |
Interest Coverage | -404.95 |
Return on Equity | 36.89% |
Return on Assets | -54.52% |
Return on Invested Capital | -61.65% |
Dividend Yield | n/a |
Payout Ratio | n/a |
FCF Payout Ratio | n/a |
Gross Profit Margin | n/a |
Net Profit Margin | n/a |
Pretax Profit Margin | n/a |
Operating Profit Margin | n/a |
FCF Margin | n/a |
EBITDA Margin | n/a |
Add to Watchlist
Select watchlists to add or remove EIKN